Fmoc-L-Arg(Boc)2-OH

Fmoc-L-Arg(Boc)2-OH is an Fmoc-protected L-arginine derivative bearing two Boc-protecting groups on the guanidinium side chain, yielding a highly protected, cation-masked amino acid building block. The molecule contains an Fmoc carbamate at the α-amino position and a carboxylic acid at the α-carboxyl terminus, enabling controlled peptide coupling while suppressing undesired side-chain reactivity during synthesis. The stereogenic center at the α-carbon is fixed as L-configuration, and the Boc/Boc-masked guanidinium functionality can be selectively unmasked under standard deprotection conditions to restore strong hydrogen-bonding and ionic character. The protected guanidine architecture and orthogonal protection pattern make the compound well suited as a chiral intermediate for peptide construction, chemical ligation handles, and downstream derivatization workflows.

1. Peptide Synthesis

Fmoc-L-Arg(Boc)2-OH is used in peptide building workflows where orthogonal protection of the arginine side chain is required to maintain coupling fidelity. The Fmoc group enables base-labile N-terminal deprotection, while the dual Boc-protected guanidinium suppresses nucleophilic side reactions and minimizes aggregation-prone behavior during chain assembly. The α-carboxylic acid and Fmoc-protected α-amino group support standard amide bond formation strategies, allowing incorporation of an L-arginine residue into protected peptide sequences. The resulting peptide products can be obtained with guanidinium restored after side-chain deprotection, supporting formation of salt-bridge and hydrogen-bonding motifs relevant to peptide science and biomolecular recognition studies.

2. Protected Amino Acids

Fmoc-L-Arg(Boc)2-OH serves as a protected amino acid intermediate for N-protected amino acid chemistry and orthogonally protected side-chain design. The Fmoc carbamate at the α-amino terminus and the Boc-protected guanidine provide a controlled reactivity profile, where side-chain functionality remains masked during coupling, purification, and iterative synthesis steps. The dual Boc strategy can be applied to regulate deprotection sequence and to manage guanidinium protonation state during synthetic operations. Downstream, the restored arginine functionality after deprotection can be leveraged for generating cationic peptide analogs, affinity reagents, and chemically defined intermediates for further amino acid derivatization.

3. Bioconjugation Chemistry

Fmoc-L-Arg(Boc)2-OH can be applied to bioconjugation and chemical biology workflows requiring arginine-containing linkers or cationic handles for controlled molecular recognition. The guanidinium side chain, once deprotected, provides strong electrostatic and hydrogen-bonding interactions that can influence conjugate solubility, binding to nucleic acids or acidic biomolecules, and membrane-interacting behavior of peptide constructs. The protected form supports incorporation into peptide-based targeting motifs, enzymatically cleavable linkers, or spacer segments that later undergo guanidinium unmasking as part of a conjugation sequence. The amino acid backbone and orthogonal protection pattern enable modular assembly of conjugates used in biochemical assay development, molecular probe generation, and scaffold optimization.

4. Peptidomimetics And SAR

Fmoc-L-Arg(Boc)2-OH is suitable for peptidomimetic design and structure-activity relationship (SAR) studies where arginine-like cationic pharmacophores are incorporated into non-natural or constrained scaffolds. The protected guanidinium functionality can be unmasked to provide a defined hydrogen-bonding and ionic interaction pattern, supporting rational tuning of binding interfaces in receptor or enzyme-focused SAR campaigns. The Fmoc-protected α-amino group and carboxylic acid facilitate stepwise synthesis of analog series, including incorporation into cyclic peptides, stapled frameworks, or side-chain-functionalized variants. The resulting arginine-containing analogs can be used as chemically consistent probes to map interaction determinants and to generate structure-defined libraries for medicinal chemistry research.

5. Pharmaceutical Manufacturing

Fmoc-L-Arg(Boc)2-OH supports manufacturing-relevant peptide intermediate preparation where protected arginine residues must be handled with predictable reactivity and minimized side reactions. The Fmoc group provides a standardized N-terminal protection strategy compatible with scalable solid-phase peptide synthesis workflows, while the dual Boc-protected guanidinium reduces undesired guanidine-mediated side processes during assembly and purification. The compound's defined stereochemistry and functional group protection profile facilitate reproducible incorporation into peptide drug substance intermediates and reference standards for analytical characterization. Downstream deprotection yields arginine-containing peptide segments with restored cationic character, enabling consistent downstream processing for formulation studies and chemical manufacturing of peptide-based materials.

1. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L

2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

3. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

4. Emu oil in combination with other active ingredients for treating skin imperfections

5. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging